ACT records first death linked to highly potent synthetic opioid

The woman's body was found at her home by a housemate who called emergency services, with post-mortem testing revealing quantities of multiple drugs in her blood including protonitazene, a synthetic opioid estimated to be at least 100 times more potent than heroin.

Coroner Ken Archer noted that the woman had been using illicit drugs, predominantly heroin, for several years and had overdosed while riding a bus days before her death. He said that while she sought drug counselling opportunities, the complexity of her dual diagnosis — deteriorating mental health and ongoing addiction issues — required a holistic response that was not achieved.

"Her response was to withdraw from support and her engagement with treatment services was limited," the coroner said.

Police found items at the home consistent with drug use, including uncapped syringes, empty clip-seal bags with presumed residue, cannabis seeds, naloxone (a single-dose nasal spray for opioid overdose), fentanyl test strips, a sharps container, a large number of prescription medications, and three bottles of methadone.

During an unrelated raid on a Canberra-based drug syndicate, police discovered the woman's name in a notebook that appeared to be a customer 'tick list', alongside a large quantity of synthetic opioids.

The forensic pathologist indicated that even low levels of protonitazene can be highly potent and may have added to respiratory depression, but concluded it was not possible to determine if the substance alone caused her death.

Why This Matters

This is the first confirmed Canberra death linked to a synthetic opioid of this class, signaling the arrival of extremely potent drugs in the ACT's illicit market that are far stronger than heroin.
The case highlights gaps in the health system's ability to provide holistic, long-term support for people with co-occurring mental health and addiction issues.
The discovery of the woman's name in a drug syndicate's notebook demonstrates the ongoing overlap between street-level supply and organised criminal networks in Canberra.

Background

Protonitazene belongs to a class of synthetic opioids called nitazenes, which emerged overseas as substitutes for fentanyl and other opioids. These novel psychoactive substances (NPS) are often manufactured illicitly and can be many times more potent than heroin, making overdoses more likely and harder to reverse with standard doses of naloxone. Since 2022, the ACT has operated a drug-checking service called CanTEST, which allows people to have substances tested anonymously for harmful adulterants.

Key Perspectives

Coroner Ken Archer: Emphasised the need for holistic care addressing both mental health and addiction, noting the woman could not engage with services at a level sufficient to develop that response. Forensic pathologist: Stated that while protonitazene could have contributed to respiratory depression, it was not possible to determine it as the sole cause of death given the mixture of drugs present. ACT drug policy observers: The case underscores the risks of highly potent synthetic opioids entering local markets and the difficulty of preventing overdoses among vulnerable users who may withdraw from support.

What to Watch

Further coronial recommendations for improving integrated mental health and addiction services in the ACT.
Whether law enforcement and drug-checking services detect more synthetic opioids like protonitazene in Canberra.
Potential policy responses regarding harm reduction measures, such as increased access to naloxone or targeted outreach.

ZOTPAPER